Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
MINOGUE MICHAEL R
   2. Issuer Name and Ticker or Trading Symbol
ABIOMED INC [ABMD] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
President, CEO, Chairman
(Last)
(First)
(Middle)
C/O ABIOMED, INC.,, 22 CHERRY HILL DRIVE		 3. Date of Earliest Transaction (Month/Day/Year)
04/04/2011
(Street)

DANVERS, MA 01923		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.01 par value 04/04/2011   M   139,088 A $ 9.05 360,077 D  
Common Stock, $.01 par value 04/04/2011   S(8)   172,986 D $ 15.006 (9) 187,091 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (1) $ 9.05 04/04/2011   M     94,892 04/05/2005(4) 04/05/2014 Common Stock 94,892 $ 0 5,108 D  
Stock Option (right to buy) (3) $ 9.05 04/04/2011   M     44,196 04/05/2005(4) 04/05/2014 Common Stock 44,196 $ 0 55,804 D  
Stock Option (right to buy) (2) $ 9.05             04/05/2005(4) 04/05/2014 Common Stock 192,200   186,383 D  
Stock Option (right to buy) (2) $ 9.36             06/08/2006(4) 06/08/2015 Common Stock 100,000   100,000 D  
Stock Option (right to buy) (2) $ 13.57             06/01/2007(4) 06/01/2016 Common Stock 260,000   260,000 D  
Stock Option (right to buy) (2) $ 11.27             05/30/2008(4) 05/30/2017 Common Stock 85,000   85,000 D  
Stock Option (right to buy) (2) $ 13.8             05/23/2009(4) 05/23/2018 Common Stock 43,333   43,333 D  
Stock Option (right to buy) (6) $ 18.63             06/15/2009(5) 08/13/2018 Common Stock 93,750   93,750 D  
Stock Option (right to buy) (5) $ 5.86             05/28/2010(4) 05/28/2019 Common Stock 148,000   148,000 D  
Stock Option (right to buy) (5) $ 5.86             03/31/2010(7) 05/28/2019 Common Stock 130,500   130,500 D  
Stock Option (right to buy) (5) $ 10.03             06/03/2011(4) 06/03/2020 Common Stock 105,000   105,000 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
MINOGUE MICHAEL R
C/O ABIOMED, INC.,
22 CHERRY HILL DRIVE
DANVERS, MA 01923		   X     President, CEO, Chairman  

Signatures

 /s/ Stephen McEvoy (by power of attorney)   04/06/2011
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 1998 Equity Incentive Plan.
(2) Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
(3) Grant to reporting person of inducement option to buy shares of Common Stock under NASDAQ Marketplace Rule 4350. These options were granted outside of the Company's established stock option plans.
(4) These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
(5) Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
(6) These options become exercisable based on the achievement of certain performance milestones.
(7) These options become exerciseable upon the achievement of a certain performance milestone, based on the results of Abiomed's fiscal year ended March 31, 2010.
(8) The sale of common stock reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on 11/25/2009.
(9) This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $15.00 and $15.13. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.